ClearPoint Neuro, Inc.
CLPT
$14.70
$0.412.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.37% | 16.97% | 13.69% | -14.05% | -34.40% |
| Total Depreciation and Amortization | 30.61% | 56.49% | 91.21% | 100.24% | 87.52% |
| Total Amortization of Deferred Charges | -10.53% | 17.86% | 3.57% | 3.57% | 3.64% |
| Total Other Non-Cash Items | -8.32% | 4.10% | 27.86% | 66.67% | 93.58% |
| Change in Net Operating Assets | 492.98% | 156.35% | 98.15% | 97.18% | 91.70% |
| Cash from Operations | 34.77% | 43.16% | 46.40% | 32.42% | 15.14% |
| Capital Expenditure | 61.65% | 95.51% | 55.01% | -79.81% | -183.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.77% | -100.79% | 193.24% | 192.21% |
| Cash from Investing | -103.07% | -100.96% | -102.06% | 185.01% | 183.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,183.20% | 3,012.69% | 2,972.56% | 2,152.02% | -32.08% |
| Repurchase of Common Stock | -101.90% | -117.92% | 2.63% | -4.40% | 37.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,990.88% | 1,637.47% | 12,921.60% | 3,978.30% | -27.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.16% | -149.18% | 117.04% | 148.67% | 83.11% |